Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while reducing the diagnostic interference of vaccine antibodies

Simple item page
dc.contributor.authorLópez Fernández, Nerea
dc.contributor.authorAndrés Barranco, Sara
dc.contributor.authorMiguel López, María Jesús de
dc.contributor.authorSalvador Bescós, M.
dc.contributor.authorZúñiga Ripa, Amaia
dc.contributor.authorIriarte, Maite
dc.contributor.authorBlasco Martínez, José María
dc.contributor.authorMoriyón Uria, Ignacio
dc.contributor.authorConde Álvarez, Raquel
dc.contributor.authorMuñoz Álvaro, Pilar María
dc.contributor.orcidAndrés Barranco, Sara [0000-0002-4127-234X]
dc.contributor.orcidMuñoz Álvaro, Pilar María [0000-0002-7970-4929]
dc.date.accessioned2026-02-27T18:10:45Z
dc.date.available2026-02-27T18:10:45Z
dc.date.issued2024-11-09
dc.date.updated2026-02-04T09:40:03Z
dc.description.abstractAIM OF THIS WORK: To evaluate the use of the conjunctival route as a strategy to reduce the persistence of H38ΔwbkF vaccine antibodies while maintaining protection against B. ovis.
dc.description.sponsorshipResearch supported by MCIN/AEI (projects PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 and PID2019107601RA-C32), Aragón Goverment (A23-21R) and REPRODIVAC / Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact from the EU Horizon research and innovation program under Grant Agreement No. 101060313. Acknowledgements: Sara Serrano for her excellent technical assistant.
dc.identifier.citationLópez-Fernández, N., Andrés-Barranco, S., De Miguel, M. J., Salvador-Bescós, M., Zúñiga-Ripa, A., Iriarte, M., Blasco, J. M., Moriyón, I., Conde-Álvarez, R., & Muñoz, P. M. (2025). Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while reducing the diagnostic interference of vaccine antibodies [Póster]. En: International Veterinary Vaccinology Network Conference 2024 (Ho Chi Minh City. Vietnam. 2024)
dc.identifier.urihttps://hdl.handle.net/10532/8168
dc.language.isoen
dc.relationinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2023-146797OB-C32/ES/AVANZANDO EN VACUNAS SEGURAS CONTRA LA BRUCELOSIS OVINA: EFICACIA DE CANDIDATOS VACUNALES MEJORADOS DE B. MELITENSIS Y B. OVIS Y MODELOS IN VITRO INNOVADORES/BruVac-Cell
dc.relationinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-107601RB-C31/ES/Brucellosis ovina: vacunas seguras y estrategias DIVA frente a B. melitensis y B. ovis/Bru-DIsafe
dc.relation.citaSi
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.agrovocBrucella ovis
dc.subject.agrovocVacuna
dc.subject.agrovocBrucella melitensis
dc.subject.sdgHambre cero
dc.titleConjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while reducing the diagnostic interference of vaccine antibodies
dc.typepóster no publicado en actas de congreso
dc.type.hasVersionversión publicada

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
10261946.pdf
Size:
564.33 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Trabajos presentados en congresos u otros eventos